The evolution of the avidity of HIV-1-specific antibodies is prevented by early treatment started during primary HIV-1 infection

被引：0
|
作者：
Selleri, M.
Zaniratti, M.
Orchi, N.
Corpolongo, A.
Zaccaro, P.
Ippolito, G.
Capobianchi, M.
Girardi, E.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0924-8579(07)71755-7
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S550 / S550
页数：1
相关论文
共 50 条
  • [21] HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication
    Jassoy, C
    Walker, BD
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1997, 18 (03): : 341 - 354
  • [22] HIV-1 gp120 glycosylation is cell type-specific and influences reactivity with HIV-1-specific antibodies
    Raska, M.
    Elliott, M. C.
    Hall, S.
    Czernekova, L.
    Zachova, K.
    Moldoveanu, Z.
    Brown, R.
    Mestecky, J.
    Novak, J.
    CENTENNIAL RETROVIRUS MEETING, 2010, : 55 - 59
  • [23] Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization
    Robbins, GK
    Addo, MM
    Troung, H
    Rathod, A
    Habeeb, K
    Davis, B
    Heller, H
    Basgoz, N
    Walker, BD
    Rosenberg, ES
    AIDS, 2003, 17 (08) : 1121 - 1126
  • [24] Broad Recognition of Circulating HIV-1 by HIV-1-specific CTLs With Strong Ability to Suppress HIV-1 Replication
    Kuse, Nozomi
    Murakoshi, Hayato
    Akahoshi, Tomohiro
    Yu, Zhang
    Chikata, Takayuki
    Borghan, Mohamed Ali
    Gatanaga, Hiroyuki
    Sakai, Keiko
    Oka, Shinichi
    Takiguchi, Masafumi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 171 - 171
  • [25] Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL
    Yang, OO
    Sarkis, PTN
    Trocha, A
    Kalams, SA
    Johnson, RP
    Walker, BD
    JOURNAL OF IMMUNOLOGY, 2003, 171 (07): : 3718 - 3724
  • [26] Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
    Gianella, Sara
    von Wyl, Viktor
    Fischer, Marek
    Niederoest, Barbara
    Battegay, Manuel
    Bernasconi, Enos
    Cavassini, Matthias
    Rauch, Andri
    Hirschel, Bernard
    Vernazza, Pietro
    Weber, Rainer
    Joos, Beda
    Guenthard, Huldrych F.
    ANTIVIRAL THERAPY, 2011, 16 (04) : 535 - 545
  • [27] No HIV-1 molecular evolution on long-term antiretroviral therapy initiated during primary HIV-1 infection
    Abdi, Basma
    Thuy Nguyen
    Brouillet, Sophie
    Desire, Nathalie
    Sayon, Sophie
    Wirden, Marc
    Jary, Aude
    Achaz, Guillaume
    Assoumou, Lambert
    Palich, Romain
    Simon, Anne
    Tubiana, Roland
    Valantin, Marc-Antoine
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Soulie, Cathia
    AIDS, 2020, 34 (12) : 1745 - 1753
  • [28] High levels of cervical HIV-1 RNA during early HIV-1 infection
    Lavreys, Ludo
    Baeten, Jared M.
    Panteleeff, Dana D.
    Richardson, Barbra A.
    McClelland, R. Scott
    Chohan, Varsha
    Mandaliya, Kishorchandra
    Ndinya-Achola, Jeckoniah O.
    Overbaugh, Julie
    AIDS, 2006, 20 (18) : 2389 - 2390
  • [29] Quantitative HIV-1-specific antibodies as predictors of peripheral blood cell-associated HIV-1 DNA concentrations
    McManus, Margaret
    Karalius, Brad
    Patel, Kunjal
    Persaud, Deborah
    Luzuriaga, Katherine
    AIDS, 2020, 34 (08) : 1117 - 1126
  • [30] Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development
    Stephenson, Kathryn E.
    Neubauer, George H.
    Reimer, Ulf
    Pawlowski, Nikolaus
    Knaute, Tobias
    Zervveck, Johannes
    Korber, Bette T.
    Barouch, Dan H.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2015, 416 : 105 - 123
12345